Loading...

NEXTGEN PRECISION ASSAY (500 GENES+TMB+MSI) GENE PANEL BY NGS

image not found

NABL Cap Accredited 
The NextGen Precision Assay (500 Genes + TMB + MSI) Gene Panel by NGS at Metropolis Healthcare is an ultra-comprehensive tumor profiling test designed to detect a wide range of mutations, fusions, copy number variations, and genomic signatures. This advanced panel evaluates over 500 cancer-associated genes along with Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI). Metropolis Healthcare uses state-of-the-art high-depth sequencing and robust analytics to deliver precise, clinically actionable insights. It is ideal for patients requiring extensive molecular characterization to guide targeted therapy and immunotherapy decisions.

 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 65,000.00

Sample Type: EDTA Blood,Paraffin Block

Fasting Not Required


Notes:N8209

Frequently Asked Questions (FAQ's):

What does the NextGen Precision Assay (500 Genes + TMB + MSI) at Metropolis Healthcare include?
It covers 500 genes, detects key mutations, fusions, CNVs, and reports TMB and MSI for comprehensive tumor profiling.

How does Metropolis Healthcare perform this extensive genomic panel?
Metropolis Healthcare uses high-depth Next-Generation Sequencing with advanced bioinformatics pipelines to ensure accurate analysis.

Who should consider this test at Metropolis Healthcare?
Patients with solid tumors needing broad molecular insights for precision oncology and therapy selection should consider this test.

Is fasting required for this genomic test at Metropolis Healthcare?
No fasting is needed; the test uses tumor tissue and/or blood samples as advised by the treating clinician.

How long do results take at Metropolis Healthcare?
Results generally take 2–3 weeks due to the extensive genomic evaluation and variant interpretation.

Can this panel at Metropolis Healthcare help identify targeted and immunotherapy options?
Yes, it highlights actionable mutations, TMB, and MSI status to guide both targeted therapies and immunotherapy decisions.

How accurate is the 500-gene sequencing performed by Metropolis Healthcare?
Metropolis Healthcare maintains high analytical accuracy through deep sequencing coverage and strict QC parameters.

Does this panel assist in long-term cancer management at Metropolis Healthcare?
Yes, its comprehensive molecular insights support personalized treatment planning, prognosis assessment, and therapy optimization.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab